Glutamic Acid Decarboxylase Autoantibody Syndrome Presenting as Schizophrenia

Central Nervous System Destruction Mediated by Glutamic Acid Decarboxylase-Specific CD4+ T Cells

(2010) A. R. Burton et al.   JOURNAL OF IMMUNOLOGY

Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy

(2009) Suvi Liimatainen et al.   EPILEPSIA

Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy

(2009) Hans-Gert Bernstein et al.   Expert Review of Neurotherapeutics

Decreased glutamic acid decarboxylase67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders

(2009) Mia Thompson et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association

(2008) Albert Saiz et al.   BRAIN

Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies

(2008) Sabrina Matà et al.   JOURNAL OF NEUROIMMUNOLOGY